← feed

Is NCT03380455 results overdue?

Yes — results are overdue. Primary completion was 2018-01-29; the FDAAA-801 reporting deadline (2019-01-29) passed 2700 days ago and no results are posted on ClinicalTrials.gov.

Effect of Cimetidine on the Pharmacokinetics of Lucerastat in Healthy Subjects

NCT IDNCT03380455 ↗
SponsorIdorsia Pharmaceuticals Ltd. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-01-29 (ACTUAL)
Reporting deadline2019-01-29 (completion + 365d)
Days overdue2700
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 0c254f5c7a5cd429… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03380455. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →